Host Jackie Lee discusses the 340(b) Drug Pricing Program with Tony Pistilli of Axene Health Partners. Learn about the program's history and the significant growth it has seen in recent years to now account for almost 8% of all outpatient drug sales while concerns about potential abuse and unintended consequences have also increased.